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SUMMARY
A total of 63 different cell lines originating from a variety of mammalian species were cultured in
vitro and analysed for the presence of vimentin, employing polyacrylamide gradient slab gel
electrophoresis in urea/acetic acid as buffer system. Irrespective of the cell culture conditions, and
the growth potential and morphology of the cells, vimentin was expressed in all cell lines examined,
with two exceptions: MPC-11 mouse myeloma and M0PC-31C mouse plasmacytoma cells.
Immunoblotting with the monoclonal antibody ct-IFA, which is directed against an antigenic
determinant shared by all classes of intermediate filaments, did not detect any other of the known
intermediate filament proteins in MPC-11 and M0PC-31C cells.
Vimentin synthesized by various cell lines was characterized by four different criteria: (1) its
extractability with Triton X-100 under various ionic conditions; (2) its behaviour in (NH^SCU
fractionation of cellular extracts; (3) its electrophoretic mobility in polyacrylamide gel
electrophoresis in urea/acetic acid; and (4) the co-isolation of polypeptides of higher electrophoretic
mobility, which, by comparison with degradation products of vimentin obtained with the Ca2+-
activated proteinase specific for intermediate filament proteins in vitro, were identified as products
of Ca2+-dependent proteolysis of vimentin. Although the degradation products occurred in different
ratios in extracts of different cell lines, they constituted the same characteristic set of proteins
whenever degradation of vimentin was observed. The formation of proteolytic breakdown products
could be partially to totally suppressed when the cells were harvested, washed and processed in the
presence of EGTA and proteinase inhibitors.
The experimental data show that: (1) vimentin, as well as the Ca2+-activated proteinase specific
for intermediate filament proteins, is highly conserved during the evolution of mammalian species;
(2) the proteolytic breakdown products of vimentin, which give rise to a characteristic 'staircase' in
two-dimensional gel electrophoresis, are probably artefacts of isolation; (3) the expression of vimen-
tin is neither a prerequisite for nor necessarily indicative of rapid cell proliferation in vitro; and (4)
the techniques described can be used for the routine identification of vimentin in cells and tissues
in case vimentin-specific antibodies are not available.
INTRODUCTION
Indirect immunofluorescence microscopy of vertebrate tissues has shown that in
situ certain cell types are characterized by only one type of intermediate filament
system (for reviews on intermediate filaments, see Anderton, 1981; Goldman et al.
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1979; Franke et al. 1982; Lazarides, 1980, 1982a; Osborn et al. 1982). However,
during development more than one intermediate filament system can contribute to the
cytoskeletal makeup of the same cell (Bignami, Raju & Dahl, 1982; Dahl, Strocchi
&Bignami, 1982; Lazarides, 19826; Schmide/a/. 1982; Schnitzer, Franke&Schach-
ner, 1981; Shaw, Osborn & Weber, 1981; Tapscott, Bennett & Holtzer, 1981a;
Tapscott et al. 19816; Yen & Fields, 1981). In all cases reported, vimentin was the
subunit protein that was expressed in addition to tissue-specific filament proteins. In
astrocytes of rat brain and spinal cord also, the muscle cell-specific filament protein
desmin could be localized as well as glial fibrillary acidic protein (Dahl & Bignami,
1982). Moreover, when differentiated vertebrate cells were removed from their
natural environment and taken into cell culture, they all expressed vimentin as a
second intermediate filament protein (Cremer et al. 1981; Darmon, Buc-Caron,
Paulin & Jacob, 1982; Franke et al. 1979, 1981; Jacobs, Choo & Thomas, 1982;
Osborn, Franke & Weber, 1980; Quinlan & Franke, 1982; Sharp, Osborn & Weber,
1982; Virtanen et al. 1981a,b). From this observation that all proliferating cultured
cells contain vimentin-type filaments in addition to tissue-specific filaments, it was
concluded that vimentin expression is connected with the adaptation of cells to in vitro
culture conditions (Franke et al. 1979; Paulin et al. 1982; Virtanen et al. 1981a).
There was, thus far, only one exception to this rule: MHiCi hepatoma cells, which,
although they proliferate rapidly, do not synthesize vimentin (Franke et al. 1981).
In the course of our studies on several biochemical aspects of intermediate fila-
ments, particularly on the structure-function relationship of vimentin, we have
propagated 63 different mammalian cell lines and analysed them for the presence of
vimentin. In this paper we describe techniques for the extraction of vimentin from
these cells and its polyacrylamide gel electrophoretic identification. Although these
methods allow only a semiquantitative estimation of the vimentin content of in-
dividual cell lines, they are nevertheless useful in the screening of mammalian cells
for the presence of vimentin in case vimentin-specific antibodies are not available.
MATERIALS AND METHODS
Materials
Horse serum and all media used for cell culture were obtained from Flow Laboratories (Irvine,
Scotland). Foetal calf serum was purchased from Boehringer Mannheim (Mannheim, FRG) and
Seromed (Miinchen, FRG), penicillin G, streptomycin, mycostatin, phenylmethylsulphonyl
fluoride (PMSF) and Triton X-100 from Serva (Heidelberg, FRG). L-1-tosylamido-
2-phenylethylchloromethyl ketone (TPCK) was supplied by Sigma (St Louis, Mo., U.S.A.). All
other chemicals were of reagent grade and obtained from Merck AG (Darmstadt, FRG). The
monoclonal antibody a-IFA was a gift from Dr A. Dowding and Dr B. Anderton (London, Eng-
land).
Cells
The following cell lines were obtained from The American Type Culture Collection (Rockville,
Md, U.S.A.): MMT 060562, mouse mammary tumour, CCL51; Neuro-2a, mouse neuroblastoma,
CCL131; Balb/3T3 clone A31, mouse embryo, CCL163; SV-T2 mouse embryo, SV40 virus-
transformed Balb/3T3, CCL163.1; TCMK-1, mouse kidney, SV40 virus-transformed, CCL139;
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3T6-Swiss albino, mouse embryo, CCL96; K-Balb (K-234), mouse embryo, Kirsten murine sar-
coma virus-transformed Balb/3T3, CC1163.3; 3T3-Swiss albino, mouse embryo, CCL92; LC-S40,
rat Leydig cell testicular tumour, CCL43; Dede, Chinese hamster lung, CCL39; 104C1, guinea pig
embryo, transformed, CRL1405; IMR-33, gerbil fibroma, CCL146; TblLu (NBL-12), bat lung,
CCL88; Sf 1 Ep (NBL-11), cotton tail rabbit epidermis, CCL68; PtKl (NBL-3), marsupial kidney,
CCL35; PtK2 (NBL-5), marsupial kidney, CCL56; MvlLu (NBL-7), mink lung, CCL64; AK-D,
cat lung, CCL150; CRFK, cat kidney, CCL94; D-17, canine primary osteogenic sarcoma,
CCL183; MDCK (NBL-2), canine kidney, CCL34; DoCli (S+L"), canine kidney, Moloney
murine sarcoma virus-infected, CCL34.1; ChlEs (NBL-8), goat oesophagus, CCL73; PK(15),
porcine kidney, CCL33; EBTr (NBL-4), bovine embryonic trachea, CCL44; MDBK (NBL-1),
bovine kidney, BVD infected, CCL22; E.Derm (NBL-6), equine dermis, CCLS7; LLC-MK2
original, Rhesus monkey kidney, CCL7; BS-C-1, African green monkey kidney, CCL26; CV-1,
African green monkey kidney, CCL70; Vero, African green monkey kidney, CCL81; WI-38,
human lung, diploid, CCL75; WI-38 VA13 subline 2RA, human lung, SV40 virus-transformed,
CCL75.1; WI-26 VA4, human lung, SV40 virus-transformed, CCL95.1; Detroit 532, human skin,
CCL54; Detroit 550, human skin, CCL109; MPC-11, mouse myeloma, CCL167; MOPC-31C,
mouse plasmacytoma, CCL130.
DrG. Darai(Universitat Heidelberg, FRG) provided us with the following cell lines: LET, lamb
embryo testis; SK, porcine kidney; TEF, tupaia embryo fibroblasts; TEK-646-1, tupaia embryo
kidney; HF-TAV, adenovirus-transformed marmoset skin fibroblasts; OMK2/22, owl monkey
kidney.
Dr M. Schweiger and Dr M. Hirsch-Kaufmann (UniversitSt Innsbruck, Austria) made the
following cell lines available to us: SV3T3, mouse embryo, SV40 virus-transformed; Roll, human
amnion; KoII, human skin.
From Dr J. R. Sheppard (University of Minnesota, Minneapolis, Minn., U.S.A.) we obtained
the following cell lines: C6-2, rat glial tumour; Novikoff hepatoma, rat liver tumour; HTC-1, rat
liver tumour.
Ehrlich ascites tumour (EAT) cells adapted to cell culture conditions were obtained from Dr A.
Shatkin (The Roche Institute, Nutley, N.J., U.S.A.), HeLa S3 cells (cervic carcinoma) from Dr
D. Gallwitz (Universitat Marburg, FRG), BHK-21/C13/Aj281 cells (baby hamster kidney) from
Dr S. H. Revell (Institute for Cancer Research, London, England) and L929 cells (mouse connec-
tive tissue) and RK13 cells (rabbit kidney) from Dr G. Rutter (Pette Institut, Hamburg, FRG).
MESF (mouse embryo skin fibroblasts), RESF (rat embryo skin fibroblasts), HEF (hamster em-
bryo fibroblasts), GPEF (guinea pig embryo fibroblasts), CESF (cat embryo skin fibroblasts) as
well as cell lines derived from cat embryo kidney, cat embryo liver and cat embryo thymus were
obtained from whole embryos or foetal organs by standard techniques.
Cell culture
The cells obtained from The American Type Culture Collection were propagated in media whose
compositions are specified in the Catalogue of Strains II, 2nd edn (1979). The remaining cell lines
were propagated in the following media: In MEM: SV3T3 (5 % foetal calf serum (FCS)), MESF
(10% FCS), RESF (10% FCS), HEF (10% FCS), GPEF (10% FCS), RK13 (10% FCS),
CESF (10% FCS), TEF (10% FCS), TEK-646-1 (10% FCS plus non-essential amino acids),
Roll (20% FCS), KoII (20% FCS); in DMEM: C6-2 (10% FCS), HTC-1 (10% FCS), BHK-
21/C13/A3281 (10% FCS); in RPMI 1640: LET (10% FCS), SK (10% FCS), HF-TAV (10%
FCS), OMK2/22 (15 % FCS). All cells were grown in monolayer culture in standard-sized roller
bottles in the presence of 100 mg/ml streptomycin, 63-5 mg/1 penicillin G and 5-7 mg/l mycostatin
and 5% COj in the atmosphere. L929, HeLa S3, EAT and Novikoff hepatoma cells were
propagated in suspension culture using MEM supplemented with antibiotics and 5% FCS. The
MEM used for suspension culture did not contain Ca2+. MPC-11 cells were grown in suspension
culture in Dulbecco's modified Eagle's medium supplemented with 20% heat-inactivated horse
serum and antibiotics, MOPC-31C cells were also grown in suspension culture in Leibovitz's
medium L-15 supplemented with 20% FCS and antibiotics.
When the monolayer-grown cells had reached confluency, the media were decanted and the roller
bottles cooled on ice/water. The cells were scraped off the substratum with the aid of a rubber
policeman in cold lOmM-Tris-acetate (pH7-6), 0-15M-NaCl (Tris-saline) in the absence or the
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presence of 1 mM-EGTA (ethylene glycol bis (/3-aminoethylether)-A'hA/'-tetra-acetic acid), 1 mM-
PMSF, 1 mM-TPCK and 2 % DMSO (dimethyl sulphoxide) as specified in Results. They were
pelleted by centrifugation at 1500 g,v for 5min, washed with harvesting buffer and immediately
frozen in liquid N2 . The cells were stored at — 80°C until use. Suspension-grown cells were pelleted
by centrifugation at \500g,v for 5 min and processed as specified above. All following operations
were carried out, if not specified otherwise, at 0°C.
Extraction of cells
In the first series of extractions, on average 2g portions of frozen cells were thawed at 4°C in
30 rnM-Tris-acetate (pH7-6), 3mM-EDTA, 6rnM-2-mercaptoethanol, 0 5 % (w/v) Triton X-100
in the absence or in the presence of 1 mM-PMSF and 1 mM-TPCK, as specified in Results. The cells
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
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were extracted with one 15 ml and two 10 ml portions of extraction buffer by 10 strokes each time
in tightly fitting all-glass Dounce homogenizers. After each extraction, the nuclear material was
pelleted by centrifugation at 35 000^iv for 5 min. The combined supernatants were recentrifuged
at 35 000 g,v for 5 min and the pellets were combined with the corresponding major pellets of nuclear
material.
The volume of the supernatants was adjusted to 39 ml and vimentin was precipitated by dissolving
5-2g solid (NhU^SO* (23 % saturation). After shaking for 1 h, the precipitates were collected by
centrifugation at 35 000gtv for 30 min. Whereas the vimentin-free supernatants were discarded, the
pellets were dissolved in lOmM-Tris-acetate (pH7-6), 3mM-EDTA, 6mM-2-mercaptoethanol by
sonication. The volume (in ml) was equal to the mass of cells (in g) used for extraction; 0-2ml of
each solution was mixed with 0-5 ml 10% trichloroacetic acid. The precipitates were collected by
centrifugation at 2000g.v for 5 min, washed with lml acetone and dissolved in 0-2ml 6M-urea,
0-6% acetic acid, 10% 2-mercaptoethanol by sonication. A sample (20^1) of each solution was used
for polyacrylamide gradient slab gel electrophoresis in urea/acetic acid as buffer system. For the
results, see Figs 1 and 2.
The nuclear pellets were suspended in distilled water in tightly fitting all-glass Dounce
homogenizers. The final volume was 5-5 ml; 0-6ml 2 -5M-HC1 was added to each suspension and
the mixtures were shaken for 2 h. Insoluble material was removed by centrifugation at 35 000g.v for
5 min and solubilized protein was precipitated from the supernatants by the addition of 60 ml
acetone. The precipitates were collected by centrifugation at 2000g,v for 5 min and dissolved in
6M-urea, 0-6% acetic acid, 10% 2-mercaptoethanol by brief sonication. The final volume (in ml)
of each solution was again equal to the mass of cells (in g) used for extraction. A sample (20/xl) of
each solution was subjected to polyacrylamide gradient slab gel electrophoretic analysis in urea/
acetic acid as buffer system. For the results, see Figs 1 and 2.
Another set of 2-g portions of frozen cells were extracted with one 15 ml and two 10 ml portions of
lOmM-Tris-acetate (pH7-6), 1 mM-EGTA, 4mM-magnesium acetate, 6mM-2-mercaptoethanol,
lmM-PMSF, lmM-TPCK, 0-5% (w/v) Triton X-100 by 10 strokes each time in tightly fitting all-
glass Dounce homogenizers. Interval centrifugation was at 2000g,v for 5 min. While the vimentin-
free supernatants were aspirated and discarded, the Triton-resistant residual cell structures were
extracted with 025 M-HC1 exactly as described above. The solubilized and acetone-precipitated
Fig. 1. Polyacrylamide gel electrophoretic analysis of vimentin extracted from various
mammalian cell lines in the absence of proteinase inhibitors. In vitro cultured cells were
washed with Tris-saline and extracted with Triton X-100 in a low ionic strength buffer free
of divalent cations. Vimentin was precipitated from the extracts at 23% ( N H ^ S C *
saturation and analysed by polyacrylamide gradient slab gel electrophoresis in urea/acetic
acid as buffer system. Equivalent (with respect to the mass of wet cell pellet used for
extraction) amounts of protein were applied to the gel; only the amount of HF-TAV
protein (slot 26) was reduced by a factor of 3. The arrows indicate the position of vimentin.
The satellite bands of higher electrophoretic mobility represent proteolytic breakdown
products of vimentin. Only the upper third of the gels is shown. Slots 1, L929, mouse
connective tissue cells; 2, MMT, mouse mammary tumour cells; 3, Neuro-2a, mouse
neuroblastoma cells; 4, SV3T3, SV40 virus-transformed mouse embryo cells; 5, SV2T2,
SV40 virus-transformed mouse embryo cells; 6, Balb/3T3, mouse embryo cells; 7,
TCMK-1, SV40 virus-transformed mouse kidney cells; 8, HEF, hamster embryo cells;
9, BHK-21/C13/A3281, baby hamster kidney cells; 10, Dede, hamster lung cells; 11,
PtKl, potoroo kidney cells; 12, TBILu, bat lung cells; 13, MvlLu, mink lung cells; 14,
CESF, cat embryo skin fibroblasts; 15, AK-D, cat lung cells; 16, D-17, dog primary
osteogenic sarcoma cells; 17, MDCK, dog kidney cells; 18, DoGi , moloney murine
sarcoma virus-infected dog kidney cells; 19, ChlEs, goat oesophagus cells; 20, LET, lamb
embryo testis cells; 21, EBTr, bovine embryo trachea cells; 22, E.Derm, horse dermis
cells; 23, PK15, pig kidney cells; 24, SK, pig kidney cells, 25, TEF, tupaia embryo
fibroblasts; 26, HF-TAV, adenovirus-transformed marmoset skin fibroblasts; 27, LLC-
MK2 , Rhesus monkey kidney cells; 28, HeLa S3, human epitheloid carcinoma cells; 29,
WI-38VA13, SV40 virus-transformed human lung cells; 30, EAT, mouse Ehrlich ascites
tumour cells.
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protein fractions were dissolved in 6M-urea, 0-6% acetic acid, 10% 2-mercaptoethanol by sonica-
tion. The final volume (in ml) was equal to the mass of cells (in g) used for extraction. A sample
(20/il) of each protein solution was analysed by polyacrylamide gradient slab gel electrophoresis in
urea/acetic acid as buffer system. For the results, see Fig. 3.
The amount of cells and, correspondingly, the buffer volumes used for extraction can be reduced
by a factor of 10 in the case of the first extraction series and by a factor of 20 in the case of the second
extraction series (Triton-resistant residual cell structures). When only small amounts of cells are
available, cell homogenization is carried out in Eppendorf tubes by vortexing instead of using
Dounce homogenizers.
The complexity of the protein composition of the (NH^SCU precipitates can be considerably
reduced when, instead of direct extraction of cells with Triton X-100 in the presence of EDTA, first
Triton-resistant residual cell structures are prepared in the presence of 4 mM-Mg2+ and these are
then extracted with a low ionic strength buffer in the absence of Mg2"1" (Nelson & Traub, 1982a;
Traub & Nelson, 1982). This procedure removes, besides lipids, substantial amounts of cytosolic
proteins, RNA, ribosomes and membrane proteins, which otherwise might co-precipitate with
vimentin during (NH^SO* fractionation; whereas vimentin is quantitatively retained in the cell
residues. Triton-resistant residual cell structures are prepared as described above and extracted with
two 10-ml and one 15-ml portion of lOmM-Tris-acetate (pH76) , 1 mM-EGTA, 6 mM-2-mercapto-
ethanol by 10, 15 and 20 strokes, respectively, in tightly fitting all-glass Dounce homogenizers.
Interval centrifugation is at 35 000£iv for 5min. The supernatants are combined, adjusted to
1 mM-Mg2+ or SO min-KCl and recentrifuged at 35 000g,v for 5 min. The pellets are combined with
the corresponding major fractions of chromatin. The supernatants are subjected to (NH4)2SO4
fractionation and the nuclear pellets extracted with 0-25 M-HC1 exactly as described above for the
first extraction series.
As an alternative to the (NH^SO* precipitation method, vimentin can also be quantitatively
precipitated with 2-3 mM-spermidine (Traub & Nelson, 1982). Since nucleic acids and
nucleoproteins are also precipitated, the precipitate has to be extracted with 0 ' 2 5 M - H C 1 before
polyacrylamide gel electrophoresis. This method has the advantage of the quantitative removal of
nucleic acids, which interfere with the gel electrophoretic analysis of vimentin in urea/acetic acid
as buffer system.
Polyacrylamide gradient slab gel electrophoresis and immunoblotting
The protein moieties of the (NH^SC^ precipitates, nuclear fractions and Triton-resistant
residual cell structures, all dissolved in 6M-urea, 0-6% acetic acid, 10% 2-mercaptoethanol, were
Fig. 2. Polyacrylamide gel electrophoretic analysis of vimentin extracted from various
mammalian cell lines in the absence (A) and the presence (B) of proteinase inhibitors. In
vitro cultured cells were harvested, washed and processed as outlined in the legend to Fig.
1 in the absence of proteinase inhibitors (A) and the presence of 1 mM-EGTA, 1 min-
PMSF, 1 min-TPCK(B). The protein compositions of the corresponding nuclear fractions
from cells processed in the absence of proteinase inhibitors (c) and the presence of
1 mM-EGTA, 1 mM-PMSF, 1 mM-TPCK (D) are also shown. The nuclear proteins were
solubilized with 0 ' 2 5 M - H C 1 and precipitated with acetone. Equivalent amounts of all
protein fractions were analysed by polyacrylamide gradient slab gel electrophoresis in
urea/acetic acid as buffer system. The arrows indicate the position of vimentin. Slots 1,
3T6, mouse embryo cells; 2, WI-26VA4, SV40 virus-transformed human lung cells; 3,
WI-38, human lung cells; 4, Detroit 532, human skin cells; 5, Detroit 550, human skin
cells; 6, IMR-33, gerbil fibroma cells; 7, MESF, mouse embryo skin fibroblasts; 8,
RESF, rat embryo skin fibroblasts; 9, GPEF, guinea pig embryo fibroblasts; 10,
OMK2/22, owl monkey kidney cells; 11, Roll, human amnion cells; 12, KoII, human
skin cells; 13, K-Balb, Kirsten murine sarcoma virus-transformed mouse embryo cells;
14, 3T3, mouse embryo cells; 15, LC-540, rat Leydig testicular cells; 16, BS-C-1, African
green monkey kidney cells; 17, RK13, rabbit kidney cells; 18, MDBK, bovine kidney
cells; 19, SflEp, rabbit epidermis cells; 20, CRFK, cat kidney cells; 21, 104C1, guinea pig
embryo cells; 22, CV-1, African green monkey kidney cells; 23, PtK2, potoroo kidney
cells.
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Fig. 3. Polyacrylamide gel electrophoretic analysis of the protein composition of Triton-
resistant residual cell structures derived from various mammalian cell lines. Cells were
extracted with Triton X-100 in a low ionic strength buffer containing 4mM-Mg2+,
1 ITIM-EGTA, 1 mM-PMSF and 1 mM-TPCK. The proteins of the cell residues were
solubilized with 0 - 2 5 M - H C 1 , precipitated with acetone and analysed by polyacrylamide
gradient slab gel electrophoresis in urea/acetic acid as buffer system. The position of
vimentin is indicated by an arrow. Slots 1, L929, mouse connective tissue cells; 2, SV3T3,
SV40 virus-transformed mouse embryo cells; 3, TCMK-1, SV40 virus-transformed
mouse kidney cells; 4, C6-2, ratglial tumour cells; 5, Novikoff hepatoma, rat liver tumour
cells; 6, HTC-1, rat liver tumour cells; 7, IMR-33, gerbil fibroma cells; 8, TBILu, bat
lung cells; 9, PtKl, potoroo kidney cells; 10, MDCK, dog kidney cells; 11, TEK-646-1,
tupaia embryo kidney cells; 12, Vero, African green monkey kidney cells; 13, OMK2/22,
owl monkey kidney cells; 14, HF-TAV, adenovirus-transformed marmoset skin
fibroblasts; 15, WI-26VA4, SV40 virus-transformed human lung cells; 16, Detroit 550,
human skin cells.
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analysed by polyacrylamide gradient slab gel electrophoresis in 6M-urea, 6% acetic acid as buffer
system, as described previously (Egberts, Hackett & Traub, 1976). For immunoblotting, the
monoclonal antibody a-IFA was used, which cross-reacts with an antigenic determinant shared by
all intermediate filament subunit proteins (Pruss et al. 1981). The electrophoretic transfer of
proteins from urea/acetic acid gels to nitrocellulose niters and the subsequent immunoblotting
using the peroxidase-Hanker/Yates method has been described in detail previously (Nelson &
Traub, 19826).
RESULTS
As described recently, vimentin is almost quantitatively so'lubilized when Ehrlich
ascites tumour cells grown in suspension culture are extracted with Triton X-100 in
a low ionic strength buffer free of di- and polyvalent cations (Traub & Nelson, 1982).
It can be quantitatively precipitated from the postnuclear supernatant of this extract
at 23 % (NH4)2SO4 saturation. When analysed by polyacrylamide gradient slab gel
electrophoresis in urea/acetic acid as buffer system, the (NH^SCU precipitate seems
to consist almost exclusively of vimentin. The filament protein appears as a sharp,
major band occasionally accompanied by some minor bands of higher electrophoretic
mobility representing proteolytic degradation products of vimentin (Fig. 1, slot 30).
However, when analysed by polyacrylamide gradient slab gel electrophoresis in the
presence of sodium dodecyl sulphate, the electrophoresis profile turns out to be rather
complex (data not shown); if the amount of vimentin in the (NH^SC^precipitate is
low, then the filament protein can only be identified with difficulty.
We have employed this procedure of extraction and gel electrophoretic analysis in
urea/acetic acid for the screening of a large variety of mammalian cell lines for their
potentials to synthesize vimentin. Whereas in Fig. 1 those cell lines are summarized
that have released most of their vimentin in its intact form into the postnuclear
supernatant, in Fig. 2A those cases are presented in which vimentin has been proteo-
lytically degraded to a great extent. The nuclear pellets, which had also been analysed
for their residual vimentin contents, were virtually free of vimentin (Fig. 2c, not
shown for cell lines listed in Fig. 1).
Judging from the gel electrophoretic band patterns of the breakdown products of
vimentin, which were identical to those obtained in vitro with purified vimentin and
the intermediate filament-specific, Ca2+-activated proteinase (Nelson & Traub, 1981,
1982c) (data not shown), the degradation of vimentin seemed to be due to the activa-
tion of the proteinase during harvesting and processing of the cells. In order to avoid
Ca2+-dependent proteolysis of vimentin, a second batch of the cells listed in Fig. 2A
were harvested and washed with Tris-saline in the presence of the Ca2+-chelating
agent EGTA. The proteinase inhibitors phenylmethylsulphonyl fluoride (PMSF)
and L-l-tosylamido-2-phenylmethylchloromethyl ketone (TPCK) were included in
the wash buffer to prevent non-specific proteolytic degradation of vimentin. Also, the
extraction of the cells with Triton X-100 was performed in the presence of PMSF and
TPCK. As shown in Fig. 2B, the precautions taken indeed had a positive effect on the
yield of intact vimentin. In all cases examined, the extent of proteolytic degradation
of vimentin was drastically reduced in comparison with the situation illustrated in Fig.
2A; vimentin appeared as the major protein constituent of the
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precipitates. However, if one compares in Fig. 2A and B the total staining density of
vimentin and its degradation products extracted from corresponding cell batches, in
some cases (for instance, in those of samples 4, 5, 6, 11, 12, 13, 14) the yields of
vimentin and its derivatives seemed to be higher when the cells had been washed and
processed in the absence of any inhibitors. This contradiction is only apparent since,
as shown in Fig. 2D, the corresponding nuclear pellets remaining after extraction of
the cells in the presence of inhibitors still contained substantial amounts of mostly
intact vimentin. Under proteinase-inhibitory conditions, the solubilization of vimen-
tin with Triton X-100 in low ionic strength buffer was obviously less efficient.
As was also shown previously, vimentin is quantitatively retained in detergent-
resistant residual cell structures when EAT cells are extracted with Triton X-100 in
a low ionic strength buffer containing 4mM-Mg2+ (Traub & Nelson, 1982). The
protein moiety of the residual cell structures, including vimentin and histones as the
major components, can be solubilized with 0-25 M-HCI, precipitated with acetone and
finally dissolved in urea/acetic acid buffer for polyacrylamide gel electrophoretic
analysis. In order to avoid the splitting of the vimentin complement of cells into a
soluble and a nuclear fraction as indicated in Fig. 2B and D, we have also prepared,
under proteinase-inhibitory conditions, Triton-resistant residual cell structures from
a variety of mammalian cells that had been harvested in the presence of EGTA, PMSF
and TPCK. As depicted in Fig. 3, in all cases examined, vimentin was, besides the
histones, the major protein constituent. In most cases it was accompanied by small
amounts of its high molecular weight proteolytic degradation products.
To demonstrate that the major polypeptides that, in Figs 1 and 2, migrated faster
than vimentin were indeed derived from vimentin by proteolysis, we have charac-
terized them further by immunoblotting. We have used the monoclonal antibody
cr-IFA, which defines an antigenic determinant shared by all classes of intermediate
filaments (Pruss et al. 1981). Fig. 4A, B clearly illustrates that the satellite bands of
vimentin strongly reacted with the antibody and, moreover, that proteolysis of vimen-
tin during the handling and processing of the various cells created a constant set of
identical degradation products in which, however, corresponding polypeptides were
represented in varying amounts in the different cases examined.
Altogether, we have analysed 63 different mammalian cell lines for the presence of
vimentin and its degradation products. Those that proved to be vimentin-positive are
presented in Figs 1—4 and are also listed in Table 1. Among the 63 cell lines we
detected only two, MPC-11 mouse myeloma and M0PC-31C mouse plasmacytoma
cells, that, no matter how they had been propagated, handled and processed, never
contained vimentin or its high molecular weight proteolytic degradation products. To
exclude the possibility that vimentin was synthesized only in trace amounts that
escaped detection in the urea/acetic acid gel electrophoresis system, we also analysed
the total cellular protein content of both cell preparations in the sodium dodecyl
sulphate gel electrophoresis system, in combination with the sensitive immunoblot-
ting assay. Cells harvested in the presence of EGTA, PMSF and TPCK were extrac-
ted, under proteinase-inhibitory conditions, with Triton X-100 in a low ionic strength
buffer free of divalent cations. The nuclei and the postnuclear supernatants were
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Fig. 4. Cross-reactivity of the monoclonal antibody, a-IFA, with vimentin and its proteo-
lytic degradation products extracted from various mammalian cell lines in the absence of
proteinase inhibitors. Vimentin was extracted from various mammalian cell lines, which
had been harvested in the absence of proteinase inhibitors, with Triton X-100 in a low ionic
strength buffer free of divalent cations and precipitated at 23 % (NH^SCU saturation.
After polyacrylamide gradient slab gel electrophoretic separation of the protein con-
stituents in urea/acetic acid as buffer system, these were transferred onto nitrocellulose
paper and reacted with the monoclonal antibody a-IFA, which defines a common antigen-
ic determinant shared by all intermediate filament proteins (Pruss et al. 1981). The
antibody-labelled proteins were visualized by incubation with a horseradish peroxidase-
conjugated immunoglobulin G preparation and Hanker/Yates solution plus H2O2 .A.
Coomassie Brilliant Blue-stained gel; B. immunoblot. The position of vimentin is in-
dicated by arrows. Slots 1, 3T3, mouse embryo cells; 2, MESF, mouse embryo skin
fibroblasts; 3, RESF, rat embryo skin fibroblasts; 4, 104C1, guinea pig embryo cells; 5,
RK13, rabbit kidney cells; 6, PtK2, potoroo kidney cells; 7, BS-C-1, African green
monkey kidney cells; 8, WI-38, human lung cells.
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Table 1. Compilation of vimentin-synthe sizing, cultured cells orginatingfrom different
mammalian species
Cell line Species Origin Morphology11 Fig./Slotc
1 2 3 4
L929
MMT
Neuro-2a
Balb/3T3
SV3T3
SV2T2
TMCK-1
EAT
3T6
MESF
K-Balb
3T3
RESF
LC-540
C6-2
Novikoff hepatoma
HTC-1
BHK-21/C13/A3281
Dede
HEF
GPEF
104 Cl
IMR-33
TB1 Lu
RK13
Sfl Ep
PtKl
PtK2
Mvl Lu
CESF
AK-D
CRFK
D-17
MDCK
DoCl
ChlEs
LET
PK1S
SK
EBTr
MDBK
E. Derm
TEF
TEK-646-1
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Mouse
Rat
Rat
Rat
Rat
Rat
Hamster
Hamster
Hamster
Guinea pig
Guinea pig
Gerbil
Bat
Rabbit
Rabbit
Potoroo
Potoroo
Mink
Cat
Cat
Cat
Dog
Dog
Dog
Goat
Sheep
Pig
Pig
Bovine
Bovine
Horse
Tupaia
Tupaia
Connective tissue
Mammary tumour
Neuroblastoma
Embryo
Embryo (SV40)'
Embryo (SV40)1
Kidney (SV40)1
Ehrlich ascites tumour
Embryo
Embryo skin
Embryo (KMSN)*
Embryo
Embryo skin
Leydig cell testicular
tumour
Glial tumour
Liver tumour
Liver tumour
Kidney
Lung
Embryo
Embryo
Embryo
Fibroma
Lung
Kidney
Epidermis
Kidney
Kidney
Lung
Embryo skin
Embryo kidney
Embryo liver
Embryo thymus
Lung
Kidney
Primary osteogenic
sarcoma
Kidney
Kidney (MMSV)"
Oesophagus
Embryo testis
Kidney
Kidney
Embryo trachea
Kidney
Dennis
Embryo
Embryo kidney
F
E
N
F
F
F
E
S
F
F
F
F
F
F
F
S
E
F
F
F
F
F
F
E
E
E
E
E
E
F
F
E
F
E
E
E
E
E
F
F
E
E
F
E
F
F
E
1
2
3
6
4
5
7
30
9
10
8
12
11
13
14
15
16
17
18
19
20
23
24
21
22
25
1
7
13
14
8
15
9
21
6
17
19
23
20
18
1
2
3
2
1
3
4
5
6
4
7
8
5
9
6
10
11
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Table 1. continued
Cell line
HF-TAV
LLC-MKz
OMK2/22
BS-C-1
CV-1
Vero
HeLa S3
WI-38
WI-38 VA13
WI-26 VA4
Detroit 532
Detroit 550
Roll
KoII
Species
Monkey
Monkey
Monkey
Monkey
Monkey
Monkey
Man
Man
Man
Man
Man
Man
Man
Man
Origin
Marmoset skin (AV)1
Rhesus m.kidney
Owl m.kidney
African green m.kidney
African green m.kidney
African green m.kidney
Epitheloid carcinoma
Lung
Lung (SV40)"
Lung (SV40)*
Skin
Skin
Amnion
Skin
Morphology1"
F
E
E
E
F
F
E,S
F
E
E
F
F
F
F
1
26
27
28
29
Fig./Slot0
2 3 4
10
16
22
3
2
4
5
11
12
14
13
7
12
8
15
16
°SV40, SV4O virus-transformed; MSV, Kirsten murine sarcoma virus-transformed; MMSV,
Moloney murine sarcoma virus-infected; AV, adenovirus-transformed.
b E , epithelial-like; F, fibroblast-like; N, neurone-like; S, suspension culture.
c
 In the last four columns the numbers of the slots of Figs 1-4 are listed in which the vimentin
complements of the individual cell lines have been analysed by polyacrylamide gradient slab gel
electrophoresis in urea acetic acid.
subjected directly to polyacrylamide gradient slab gel electrophoretic analysis in the
presence of sodium dodecyl sulphate and the separated proteins were transferred onto
nitrocellulose paper. However, as shown in Fig. 5, neither vimentin nor its proteolytic
degradation products were detected by the monoclonal antibody a-IFA.
DISCUSSION
Irrespective of the cell culture conditions (suspension or monolayer culture) and
the growth potential (logarithmic or stationary growth phase, transformed or non-
transformed cells) and morphology (fibroblast- or epithelial-like) of a large variety of
mammalian cell lines, with two exceptions, they all synthesized vimentin in relatively
large quantities. Although this study did not emphasize quantitative aspects, our
experimental results, nevertheless, give some evidence as to the relative amounts of
vimentin present in different cell lines. Thus, adenovirus-transformed marmoset skin
fibroblasts (Fig. 3, slot 14) were found to contain the highest amount of vimentin. But
also hamster embryo fibroblasts (Fig. 1, slot 15), dog osteogenic sarcoma cells (Fig.
1, slot 16), goat oesophagus cells (Fig. 1, slot 19), tupaia baby fibroblasts (Fig. 2, slot
25), human skin fibroblasts (Fig. 2, slots 4, 5) and Ehrlich ascites tumour cells (Fig.
1, slot 30), to mention only a few cell lines, proved to be very rich in vimentin.
Principally, all these cell lines can be used for the large-scale isolation of vimentin.
Since Ehrlich ascites tumour cells, however, have a generation time of only 12 h and
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can be conveniently grown in suspension culture with heat-inactivated normal calf
serum to high cell densities, they are most suitable for the preparation of large
amounts of pure vimentin (Nelson &Traub, 19826; Nelson, Vorgias&Traub, 1982).
One might be confronted with the problem of having to identify vimentin as a
cellular constituent, and a vimentin-specific antibody is not available. In such cases,
the technique described here can be used as a relatively fast, alternative identification
method. Vimentin is easily characterized: (1) by its retention in detergent-resistant
residual cell structures when cells propagated in vitro are extracted with Triton X-100
at low ionic strength and in the presence of 4 mM-Mg2"1"; (2) by its extractability from
detergent-resistant residual cell structures, and also from whole cells, at low salt
concentration and in the absence of Mg24*; (3) by its precipitability from such extracts
at 23% (NH^SO* saturation; and (4) by its electrophoretic mobility in
polyacrylamide gradient slab gel electrophoresis in the urea/acetic acid buffer system
(see also Traub & Nelson, 1982).
Among the various cell lines examined, we found many that were apparently
vimentin-negative or seemed to contain only low amounts of vimentin (Fig. 2A).
However, we detected substantial amounts of degradation products of vimentin in
these cell lines. That the polypeptides represented by the satellite bands of higher
electrophoretic mobility are indeed derived from vimentin was ascertained by: (1)
their reactivity with the monoclonal antibody a-IFA (Pruss et al. 1981) in immuno-
blotting (Fig. 4); (2) their identity with polypeptides generated by the Ca2+ -activated
proteinase from purified vimentin in vitro (data not shown); and (3) their characteris-
tic arrangement in a 'staircase' in two-dimensional polyacrylamide gel electrophoretic
analysis (data not shown here, but for the presentation of such a staircase see, for
instance, Nelson, Vorgias & Traub; 1982; Ochs, McConkey & Guard, 1981). Our
observations show that vimentin is extremely sensitive to Ca2+-dependent proteolysis
and that the degradation can be largely avoided by harvesting and processing of the
cells in the presence of Ca2+-chelating agents and proteinase inhibitors (Fig. 2c).
These precautions should be taken whenever vertebrate cells are analysed for the
presence of intermediate filament proteins or used for the preparation of cytoskeletal
frameworks and the isolation of intermediate filament subunit proteins.
The fact that cell lines originating from a large variety of mammalian species are
capable of synthesizing the same vimentin convincingly shows that there has been
Fig. 5. Analysis of nuclear and cytoplasmic fractions from M0PC-31C mouse plasma-
cytoma and MPC-11 mouse myeloma cells for the presence of vimentin by immuno-
blotting. Suspension-grown MOPC-31Cand MPC-11 cells were harvested and washed in
the presence of EGTA, PMSF and TPCK, and extracted in the presence of the same
proteinase inhibitors, with Triton X-100 in a low ionic strength buffer free of divalent
cations. The nuclear fractions as well as the postnuclear supernatants were subjected
directly to polyacrylamide gradient slab gel electrophoresis in the presence of sodium
dodecylsulphate. While one gel was stained with Coomassie Brilliant Blue (A), the proteins
separated on a second gel were analysed further by immunoblotting using the monoclonal
antibody a-I FA (B) . Slots 1 and 6, vimentin plus actin; 2, MOPC-31C postnuclear super-
natant; 3, MOPC-31C nuclear fraction; 4, MPC-11 postnuclear supernatant; 5, MPC-11
nuclear fraction. The position of vimentin is indicated by arrows.
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a high degree of conservation of this protein during evolution. Our results of
polyacrylamide gel electrophoretic analysis of the distribution of vimentin among
different species are in good agreement with those of previous investigations employ-
ing indirect immunofluorescence microscopy and also biochemical analysis (for
references, see the Introduction). In this study, vimentin was characterized not only
by its constant physicochemical behaviour during extraction, (NH^zSCU precipita-
tion and gel electrophoresis, but also by its potential to give rise to a characteristic and
constant set of polypeptides in response to degradation by the specific, Ca2+-activated
proteinase. Irrespective of the evolutionary distance between the various species, Figs
1-4 show constant patterns of satellite bands of vimentin, although the degradation
products are quantitatively differentially represented. The reason for this variability
is unknown; it might be due to the presence of different activators or inhibitors of the
Ca2+-activated proteinase in different cell lines or to slight differences in the handling
of the cells during their harvesting and extraction. Since the supplementation of the
wash and extraction buffers with EGTA and proteinase inhibitors led to a consider-
able, in some cases even total, suppression of the formation of breakdown products,
these polypeptides must be regarded as artefacts of isolation. From this we conclude
that in vivo the major part of vimentin is somehow protected from proteolytic
degradation and that, if the Ca2+-activated proteinase found to be specific for inter-
mediate filament proteins has a genuine function in the processing of vimentin, only
a small number of vimentin molecules are degraded, probably at very distinct loca-
tions within the cell. However, not only vimentin but also the Ca2+-activated
proteinase is conserved during evolution, as published recently (Nelson & Traub,
1982a; Traub & Nelson, 1981). This high degree of evolutionary stability points to
an important cellular function for the vimentin-proteinase system that is still a matter
of conjecture.
Among the 63 different cell lines examined, we found only two that did not express
vimentin: MPC-11 mouse myeloma and M0PC-31C mouse plasmacytoma cells.
Even after cautious harvesting of the cells in the presence of EGTA and proteinase
inhibitors, their extraction under proteinase-inhibitory conditions and the employ-
ment of the sensitive immunoblotting assay (or-IFA), the nuclear and cytoplasmic
fractions of both cell lines turned out to be totally devoid of vimentin and other
intermediate filament proteins (Fig. 5). This result is in agreement with our previous
failure to detect vimentin-specific mRNA in the poly(A)+ mRNA populations of
logarithmically growing MPC-11 and MOPC-31C cells (McTavish, Nelson & Traub,
1983). Correspondingly, the activity of the Ca2+-activated proteinase specific for
intermediate filament proteins from these cells was found to be, at the most, 20 % of
that in Ehrlich ascites tumour cells (our unpublished results). The complete absence
of vimentin from MPC-11 and MOPC-31C cells shows that vimentin expression is
neither a prerequisite for nor necessarily indicative of rapid cell proliferation as sug-
gested previously (Frankee* al. 1979; Pauline/ al. 1982; Virtanenef a/. 1981a), but
was then questioned when rapidly proliferating MHiCi hepatoma cells were found
not to synthesize vimentin (Frankee/a/. 1981). It cannot be excluded, however, that
cell lines that do not accumulate vimentin in amounts detectable by conventional
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analytical methods still produce small amounts of the filament protein that are suf-
ficient to maintain rapid cell growth. It would be interesting to find out whether cell
lines that do not synthesize vimentin still contain an intact vimentin gene and if so,
how the production of vimentin can be induced. This would allow a deeper insight
into the mechanism(s) governing the regulation of the synthesis of intermediate
filament subunit proteins in vitro and in situ.
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